Morgan Courtney, Bell Ryan, Burland Julie P, Edgar Cory M
Department of Orthopaedic Surgery, University of Connecticut, Farmington, Connecticut, U.S.A.
UConn Institute for Sports Medicine, University of Connecticut, Farmington, Connecticut, U.S.A.
Arthrosc Tech. 2023 Jun 5;12(7):e1021-e1026. doi: 10.1016/j.eats.2023.02.043. eCollection 2023 Jul.
Meniscus allograft transplantation (MAT) has been shown to be a feasible surgical option for younger patients, below 50 years of age who have meniscal insufficiency and have failed conservative treatment measures. In this technical note, we describe a procedure of harvesting and injecting bone marrow aspirate concentrate in a meniscus allograft during a MAT procedure, which may allow for longer lasting transplants and improve patient outcomes. In this technical note, bone marrow aspirate concentrate is harvested arthroscopically from the intercondylar notch at the surgical site, which prevents additional donor site morbidity, as seen with harvesting from other locations, such as the iliac crest. This also reduces operating time, since harvesting from the iliac crest requires different patient positioning and usually additional anesthesia. The authors of this surgical technique believe that biological augmentation during MATs will assist surgeons in maximizing graft survivorship and, ultimately, lead to better patient outcomes.
半月板同种异体移植（MAT）已被证明是50岁以下半月板功能不全且保守治疗措施失败的年轻患者可行的手术选择。在本技术说明中，我们描述了在MAT手术过程中采集和注射骨髓抽吸浓缩物到半月板同种异体移植物中的过程，这可能使移植更持久，并改善患者预后。在本技术说明中，骨髓抽吸浓缩物通过关节镜从手术部位的髁间切迹采集，这避免了从其他部位（如髂嵴）采集时出现的额外供区并发症。这也减少了手术时间，因为从髂嵴采集需要不同的患者体位，通常还需要额外的麻醉。这种手术技术的作者认为，MAT期间的生物增强将有助于外科医生最大限度地提高移植物存活率，并最终带来更好的患者预后。
